Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-19

Clinical Trial Update: Astragalus for Symptomatic Alleviation in High-grade Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating astragalus for symptomatic relief in high-grade lymphoma, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Astragalus (Astragalus membranaceus)

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: High-grade Lymphoma | Phase 3 | Status: NOT_YET_RECRUITING